Hinge Health, Inc. (HNGE) Reports Q2 Loss of $13.10, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts HNGE Hot Sheet
Join SI Premium – FREE
Hinge Health, Inc. (NYSE: HNGE) reported Q2 EPS of ($13.10). Revenue for the quarter came in at $139.1 million, versus $0 reported last year.
GUIDANCE:
Hinge Health, Inc. sees Q3 2025 revenue of $141-143 million, versus the consensus of $128.8 million.
Hinge Health, Inc. sees FY2025 revenue of $548-552 million, versus the consensus of $511.3 million.
For earnings history and earnings-related data on Hinge Health, Inc. (HNGE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Solid Biosciences (SLDB) Tops Q3 EPS by 5c
- PureCycle Technologies, Inc. (PCT) Tops Q3 EPS by 25c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
